AC
IBB icon

Addison Capital’s iShares Biotechnology ETF IBB Stock Holding History

Addison Capital’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.54M Buy
34,397
+1,352
+4% +$232K 1.07% 26
2026
Q1 		$5.58M Buy
33,045
+4,569
+16% +$781K 0.99% 26
2025
Q4 		$4.81M Buy
28,476
+23,143
+434% +$3.76M 1.2% 26
2025
Q3 		$770K Buy
5,333
+2,204
+70% +$301K 0.23% 83
2025
Q2 		$396K Buy
3,129
+324
+12% +$39.8K 0.14% 104
2025
Q1 		$359K Buy
2,805
+1,199
+75% +$163K 0.14% 105
2024
Q4 		$212K Sell
1,606
-24
-1% -$3.37K 0.08% 129
2024
Q3 		$237K Buy
1,630
+164
+11% +$23.7K 0.1% 126
2024
Q2 		$201K Buy
+1,466
New +$196K 0.09% 138

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Addison Capital's IBB Position: Q2 2026 in Review

Addison Capital increased its iShares Biotechnology ETF (IBB) stake by 4.1% in Q2 2026, buying an estimated $232K and bringing the position to 34,397 shares worth $6.54M. The position accounts for 1.07% of the portfolio, ranked #26.

Addison Capital first reported a position in IBB in Q2 2024 and has held it in 9 quarters since. 956 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • Addison Capital held 34,397 shares of iShares Biotechnology ETF worth $6.54M as of Q2 2026.
  • Addison Capital bought 1,352 iShares Biotechnology ETF shares in Q2 2026, an estimated $232K.
  • iShares Biotechnology ETF made up 1.07% of Addison Capital's portfolio in Q2 2026, its #26 holding.
  • Addison Capital first reported a position in iShares Biotechnology ETF in Q2 2024 and has held it in 9 quarters since.
  • 956 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Addison Capital's 13F filing for Q2 2026, filed 4 Aug 2026.